Mean amyloid levels remained below 24.1 centiloids at 3 years for participants who completed donanemab treatment by 1 year.

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

An estimated seven million in the United States suffer from Alzheimer’s. And there are an estimated 12 million unpaid family ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...

Where you live in Maryland will likely affect your quality of care if you are diagnosed with Alzheimer’s disease, according ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...

NEW JERSEY (WABC) -- U.S. Sen. Andy Kim of New Jersey is opening up about his father's Alzheimer's diagnosis and his journey ...

When neurologist Steven Arnold is deciding whether to treat an Alzheimer's patient with a new therapy, he relies on averages.

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

The locus coeruleus (LC) — a tiny, ancient brainstem structure that regulates arousal, attention and memory—plays a far more ...